Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study

Aims: Whether pioglitazone (PIO), a peroxisome proliferator-activated receptor-gamma agonist, increases the risk of developing bladder cancer has been debated for several years. The aim of this study was to investigate the in vitro effects of PIO on normal urothelial transitional epithelium (NUTE) c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Med Sci
Main Authors: Yang, Shao-ling, Wang, Ji-jiao, Chen, Ming, Xu, Lu, Li, Nan, Luo, Yi-li, Bu, Le, Zhang, Man-na, Li, Hong, Su, Ben-li
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5820852/
https://ncbi.nlm.nih.gov/pubmed/29483814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.22408
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados